Presenting initial results from the company-sponsored Phase 1/2a study of [212Pb]VMT-α-NET in patients with RPT-naïve neuroendocrine tumors at the upcoming 2024 North American Neuroendocrine Tumor ...
A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, 119991 st. Vavilova, 28, GSP-1, Moscow 119991, Russian Federation ...
Operating out of facilities in Vancouver, Alpha-9 touts its “differentiated toolbox of binders, linkers, chelators and radioisotopes” as setting apart its approach to radiopharma development.
“The future of ADCs is actually experimenting with novel payloads,” said Chris Bardon, a co-managing partner of MPM BioImpact. Bound by chelators, the radioisotopes home in on cancer or tumor cells ...
Clarity Pharmaceuticals also highlights that unlike other commercially available chelators, its SAR technology prevents copper leakage into the body. The volatility in the CU6 share price in ...